Agreement signed for development of drug-coated stent.
Agreement signed for development of drug-coated stent. STS Biopolymers (Henrietta, NY; 716/321-1130) has agreed to develop a Medi-Coat drug-delivery coating for stents manufactured by B. Braun Medical (Bethlehem, PA; 800/359-2439). The coated stents will be designed to inhibit restenosis in patients. Medi-Coat drug-delivery technology makes possible the release of single drugs or multiple-drug combinations over times ranging from days to weeks. The drugs are delivered from the polymer matrix directly to the vessel wall. When used in combination
November 1, 2001
STS Biopolymers (Henrietta, NY; 716/321-1130) has agreed to develop a Medi-Coat drug-delivery coating for stents manufactured by B. Braun Medical (Bethlehem, PA; 800/359-2439). The coated stents will be designed to inhibit restenosis in patients. Medi-Coat drug-delivery technology makes possible the release of single drugs or multiple-drug combinations over times ranging from days to weeks. The drugs are delivered from the polymer matrix directly to the vessel wall. When used in combination with primer, the Medi-Coat drug-delivery coating will adhere permanently to the stents while providing the necessary flexibility, without cracking or flaking.
You May Also Like